UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 31

Sortiert nach

The potential of CAR T cell therapy for prostate cancer

Nature reviews. Urology, 2021-09, Vol.18 (9), p.556

2021

Volltextzugriff (PDF)

TALE-PvuII fusion proteins--novel tools for gene targeting

PloS one, 2013-12, Vol.8 (12), p.e82539

2013

Volltextzugriff (PDF)

Targeted multi-epitope switching enables straightforward positive/negative selection of CAR T cells

Gene therapy, 2021-09, Vol.28 (9), p.602-612

2021

Volltextzugriff (PDF)

CRISPR-Cas12a for Highly Efficient and Marker-Free Targeted Integration in Human Pluripotent Stem Cells

International journal of molecular sciences, 2024-01, Vol.25 (2), p.985

2024

Volltextzugriff (PDF)

CRISPR-Cas9 based gene editing of the immune checkpoint NKG2A enhances NK cell mediated cytotoxicity against multiple myeloma

Oncoimmunology, 2022, Vol.11 (1), p.2081415-2081415

2022

Volltextzugriff (PDF)

Automated generation of gene-edited CAR T cells at clinical scale

Molecular therapy. Methods & clinical development, 2021-03, Vol.20, p.379-388

2021

Volltextzugriff (PDF)

Cell-Based Models of 'Cytokine Release Syndrome' Endorse CD40L and Granulocyte-Macrophage Colony-Stimulating Factor Knockout in Chimeric Antigen Receptor T Cells as Mitigation Strategy

Cells (Basel, Switzerland), 2023-11, Vol.12 (21), p.2581

2023

Volltextzugriff (PDF)

PSMA-Directed CAR T Cells Combined with Low-Dose Docetaxel Treatment Induce Tumor Regression in a Prostate Cancer Xenograft Model

Molecular therapy. Oncolytics, 2020-09, Vol.18, p.226-235

2020

Volltextzugriff (PDF)

Modeling MyD88 Deficiency In Vitro Provides New Insights in Its Function

Frontiers in immunology, 2020-12, Vol.11, p.608802-608802

2020

Volltextzugriff (PDF)

P1354: CRISPR/CAS9 GENE EDITING OF IMMUNE CHECKPOINT RECEPTOR NKG2A IMPROVES THE ANTI‐LEUKEMIC EFFICACY OF PRIMARY CD33‐TARGETING CAR‐NK CELLS

HemaSphere, 2023-08, Vol.7 (S3), p.e71265f8-n/a

2023

Volltextzugriff (PDF)

Rescue of DNA-PK Signaling and T-Cell Differentiation by Targeted Genome Editing in a prkdc Deficient iPSC Disease Model

PLoS genetics, 2015-05, Vol.11 (5), p.e1005239-e1005239

2015

Volltextzugriff (PDF)

TALENs facilitate targeted genome editing in human cells with high specificity and low cytotoxicity

Nucleic acids research, 2014-06, Vol.42 (10), p.6762

2014

Volltextzugriff (PDF)

Genome and Epigenome Editing to Treat Disorders of the Hematopoietic System

Human gene therapy, 2017-11, Vol.28 (11), p.1105

2017

Volltextzugriff (PDF)

CRISPR/Cas9 Gene Editing of Immune Checkpoint Receptor NKG2A Improves the Efficacy of Primary CD33-CAR-NK Cells Against AML

Blood, 2022-11, Vol.140 (Supplement 1), p.4558-4559

2022

Volltextzugriff (PDF)

Biodegradable Nanocarriers Resembling Extracellular Vesicles Deliver Genetic Material with the Highest Efficiency to Various Cell Types

Small (Weinheim an der Bergstrasse, Germany), 2020-01, Vol.16 (3), p.e1904880-n/a

2020

Volltextzugriff (PDF)

Targeted genome editing restores T cell differentiation in a humanized X-SCID pluripotent stem cell disease model

Scientific reports, 2017-09, Vol.7 (1), p.12475-11, Article 12475

2017

Volltextzugriff (PDF)

Non-integrating gamma-retroviral vectors as a versatile tool for transient zinc-finger nuclease delivery

Scientific reports, 2014-04, Vol.4 (1), p.4656-4656, Article 4656

2014

Volltextzugriff (PDF)

Rescue of DNA-PK Signaling and T-Cell Differentiation by Targeted Genome Editing in a prkdc Deficient iPSC Disease Model: e1005239

PLoS genetics, 2015-05, Vol.11 (5)

2015

Volltextzugriff (PDF)

TALE-PvuII Fusion Proteins - Novel Tools for Gene Targeting: e82539

PloS one, 2013-12, Vol.8 (12)

2013

Volltextzugriff (PDF)

CRISPR-Cas9 based gene editing of the immune checkpoint NKG2A enhances NK cell mediated cytotoxicity against multiple myeloma

OncoImmunology, 2022, Vol.11 (1)

2022

Volltextzugriff (PDF)

Does Environmental, Social, and Governance (ESG) Disclosure Add Firm Value? Evidence from Sharia-Compliant Banks in Jordan

Sustainable Finance, Digitalization and the Role of Technology, p.585-595

Volltextzugriff (PDF)

Rubber-based solid waste management as a partial replacement of aggregates in concrete: Advances and recent trends

AIP Conference Proceedings, 2023, Vol.2847 (1)

2023

Volltextzugriff (PDF)

Developing ensemble machine learning for estimating and parametrically assessing the moment capacity of ferrocement members

Asian journal of civil engineering. Building and housing, 2024-06, Vol.25 (4), p.3803-3813

2024

Volltextzugriff (PDF)

Engineering properties of fibre reinforced lightweight geopolymer concrete using palm oil biowastes

Australian journal of civil engineering, 2020-01, Vol.18 (1), p.82-92

2020

Volltextzugriff (PDF)

Parametric Assessment of Concrete Constituent Materials Using Machine Learning Techniques

Journal of soft computing in civil engineering, 2022-07, Vol.6 (3), p.39-62

2022

Volltextzugriff (PDF)

1 – 25 von 31

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(26)

Publikationsform

Sprache

Englisch
(31)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The potential of CAR T cell therapy for prostate cancer

TALE-PvuII fusion proteins--novel tools for gene targeting

Targeted multi-epitope switching enables straightforward positive/negative selection of CAR T cells

CRISPR-Cas12a for Highly Efficient and Marker-Free Targeted Integration in Human Pluripotent Stem Cells

CRISPR-Cas9 based gene editing of the immune checkpoint NKG2A enhances NK cell mediated cytotoxicity against multiple myeloma

Automated generation of gene-edited CAR T cells at clinical scale

Cell-Based Models of 'Cytokine Release Syndrome' Endorse CD40L and Granulocyte-Macrophage Colony-Stimulating Factor Knockout in Chimeric Antigen Receptor T Cells as Mitigation Strategy

PSMA-Directed CAR T Cells Combined with Low-Dose Docetaxel Treatment Induce Tumor Regression in a Prostate Cancer Xenograft Model

Modeling MyD88 Deficiency In Vitro Provides New Insights in Its Function

P1354: CRISPR/CAS9 GENE EDITING OF IMMUNE CHECKPOINT RECEPTOR NKG2A IMPROVES THE ANTI‐LEUKEMIC EFFICACY OF PRIMARY CD33‐TARGETING CAR‐NK CELLS

Rescue of DNA-PK Signaling and T-Cell Differentiation by Targeted Genome Editing in a prkdc Deficient iPSC Disease Model

TALENs facilitate targeted genome editing in human cells with high specificity and low cytotoxicity

Genome and Epigenome Editing to Treat Disorders of the Hematopoietic System

CRISPR/Cas9 Gene Editing of Immune Checkpoint Receptor NKG2A Improves the Efficacy of Primary CD33-CAR-NK Cells Against AML

Biodegradable Nanocarriers Resembling Extracellular Vesicles Deliver Genetic Material with the Highest Efficiency to Various Cell Types

Targeted genome editing restores T cell differentiation in a humanized X-SCID pluripotent stem cell disease model

Non-integrating gamma-retroviral vectors as a versatile tool for transient zinc-finger nuclease delivery

Rescue of DNA-PK Signaling and T-Cell Differentiation by Targeted Genome Editing in a prkdc Deficient iPSC Disease Model: e1005239

TALE-PvuII Fusion Proteins - Novel Tools for Gene Targeting: e82539

CRISPR-Cas9 based gene editing of the immune checkpoint NKG2A enhances NK cell mediated cytotoxicity against multiple myeloma

Does Environmental, Social, and Governance (ESG) Disclosure Add Firm Value? Evidence from Sharia-Compliant Banks in Jordan

Rubber-based solid waste management as a partial replacement of aggregates in concrete: Advances and recent trends

Developing ensemble machine learning for estimating and parametrically assessing the moment capacity of ferrocement members

Engineering properties of fibre reinforced lightweight geopolymer concrete using palm oil biowastes

Parametric Assessment of Concrete Constituent Materials Using Machine Learning Techniques

Suchergebnisse filtern